Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 1;36(2):319-321.
doi: 10.1097/QAD.0000000000003114.

A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults

Christine Durier  1 , Séverine Mercier-Delarue  2 , Nathalie Colin De Verdière  2 , Vincent Meiffrédy  1 , Sophie Matheron  3 , Assia Samri  4 , Martine Resch  1 , Lucie Marchand  5 , Brigitte Autran  4 , Odile Launay  6 , François Simon  2 ; ANRS NOVAA EP46 study group
Affiliations

A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults

Christine Durier et al. AIDS. .
No abstract available

PubMed Disclaimer

References

    1. WHO. Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013-Recommendations . Vaccine 2015; 33:76–77.
    1. HCSP. Statement on 2019 health recommendations for travellers (for the attention of health professionals). https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=736 . Paris, France: HCSP; 2019.
    1. Martin C, Domingo C, Bottieau E, Buonfrate D, De Wit S, Van Laethem Y, et al. Immunogenicity and duration of protection after yellow fever vaccine in people living with human immunodeficiency virus: a systematic review . Clin Microbiol Infect 2021; 27:958–967.
    1. de Verdiere NC, Durier C, Samri A, Meiffredy V, Launay O, Matheron S, et al. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients . AIDS 2018; 32:2291–2299.
    1. Mercier-Delarue S, Durier C, de Verdlere NC, Poveda JD, Meiffredy V, Garcia MDF, et al. Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype . PLos One 2017; 12:e0177882.

Publication types